HomeGALT • NASDAQ
Follow
Galectin Therapeutics Inc. Common Stock
Previous close
$2.41
Day range
$2.32 - $2.43
Year range
$1.28 - $2.48
Market cap
143.49M USD
Avg Volume
95.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.17M | 12.85% |
Net income | -10.43M | -21.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 20.36M | 28.62% |
Total assets | 22.16M | 23.72% |
Total liabilities | 73.04M | 81.46% |
Total equity | -50.87M | — |
Shares outstanding | 61.85M | — |
Price to book | -2.80 | — |
Return on assets | -108.49% | — |
Return on capital | -209.69% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -10.43M | -21.30% |
Cash from operations | -7.64M | 8.51% |
Cash from investing | — | — |
Cash from financing | 10.03M | — |
Net change in cash | 2.40M | 128.70% |
Free cash flow | -4.84M | 12.92% |
About
Founded
2000
Headquarters
Website
Employees
12